DaVita to poorly rated competitors: 'Stop being sour grapes'

By Sabriya Rice  |  May 29, 2015

Now that the federal government has finally released its quality ratings for more than 5,500 U.S. dialysis facilities, it's time to move on and work within the system—even if the system is flawed, says DaVita Kidney Care CEO Javier Rodriguez.

Humana explores sale that would shake up health insurance industry

Humana explores sale that would shake up health insurance industry

By Bob Herman  |  May 29, 2015

Health insurer Humana, Louisville, Ky., is reportedly working with an investment bank to explore a sale. Humana, one of the largest Medicare Advantage insurers in the country, has been a rumored takeover target for more than a year.

Go east, medical device makers!

By Beth Kutscher  |  May 29, 2015

Medical device makers, facing reimbursement and sales pressure in the U.S., are looking to China for opportunities as globalization becomes a key part of their strategy.

Justice Department investigating Amedisys

By Lisa Schencker  |  May 29, 2015

Amedisys, one of the nation's largest home health and hospice providers, is under investigation by the U.S. Justice Department, the company revealed in a filing with the Securities and Exchange Commission on Thursday.

New Medicare ACO rules near release

By Melanie Evans  |  May 29, 2015

The CMS is expected to issue final regulations soon that could significantly affect whether hospitals and doctors remain willing to participate in Medicare's accountable care program.

NextCare acquires three Ariz. urgent-care centers

By Adam Rubenfire  |  May 29, 2015

NextCare Holdings, a Mesa, Ariz.-based urgent-care and occupational medical services provider, has acquired three new facilities in Arizona, allowing it to provide care to more than 90% of the state's population.

Healthcare computer experts tackle EHR shortcomings

By Joseph Conn  |  May 29, 2015

A prominent association of healthcare computer experts has a new set of recommendations to address challenges clinicians face as they're expected to do more with electronic health-record systems.

Teva will pay $1.2 billion in FTC pay-for-delay settlement

By Lisa Schencker  |  May 28, 2015

Drugmaker Teva Pharmaceuticals will pay $1.2 billion to purchasers to settle allegations by the Federal Trade Commission that a company it acquired stalled generic versions of its popular sleep-disorder drug Provigil from entering the market.

Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.